Systematizing Serendipity for Cardiovascular Drug Discovery
- 21 July 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 120 (3), 255-263
- https://doi.org/10.1161/circulationaha.108.824177
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleasesNature Biotechnology, 2008
- Targeted gene inactivation in zebrafish using engineered zinc-finger nucleasesNature Biotechnology, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasisNature, 2007
- A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)Nature Protocols, 2006
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006
- Artery/Vein Specification Is Governed by Opposing Phosphatidylinositol-3 Kinase and MAP Kinase/ERK SignalingCurrent Biology, 2006
- In vivo drug discovery in the zebrafishNature Reviews Drug Discovery, 2005
- Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial ChemistryJournal of Chemical Information and Computer Sciences, 2002